SCHEMBL6555840

SCHEMBL6555840

O=C1C=C(C2=CC(=O)c3ccccc3C2=O)C(=O)c2ccccc21

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.75
CDC25B P30305 5/20 0.60
IDO1 P14902 4/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
LMNA P02545 3/20 0.60
MAPT P10636 3/20 0.60
MAOA P21397 3/20 0.60
MAPK1 P28482 3/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
CDC25A P30304 2/20 0.60
PLIN1 O60240 2/20 0.60
BLM P54132 2/20 0.60
PLIN5 Q00G26 2/20 0.60
ABHD5 Q8WTS1 2/20 0.60
ALDH1A1 P00352 2/20 0.60
MAOB P27338 2/20 0.60
SNCA P37840 2/20 0.60
NR1I2 O75469 1/20 0.60
USP2 O75604 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8596446 0.91 PTPN1 (0.64) BACE1CDC25BIDO1MEN1KMT2A
SCHEMBL5485068 0.86 BACE1 (1.00) BACE1CDC25BIDO1MEN1KMT2A
SCHEMBL29673492 0.86 BACE1 (1.00) BACE1CDC25BIDO1MEN1KMT2A
SCHEMBL9286666 0.83 BACE1 (0.60) BACE1CDC25BIDO1MEN1KMT2A
SCHEMBL1708066 0.83 BACE1 (0.60) BACE1CDC25BIDO1MEN1KMT2A
SCHEMBL28564373 0.83 BACE1 (0.60) BACE1CDC25BIDO1MEN1KMT2A
SCHEMBL7605733 0.83 BACE1 (0.60) BACE1CDC25BIDO1MEN1KMT2A
Methylamine SCHEMBL3277347 0.81 BACE1 (0.89) BACE1CDC25BIDO1MEN1KMT2A
SCHEMBL312389 0.80 BACE1 (1.00) BACE1CDC25BIDO1MEN1KMT2A
SCHEMBL8598269 0.80 BACE1 (0.59) BACE1CDC25BIDO1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115335777-A Electrophotographic photoreceptor, electrophotographic photoreceptor cartridge, and image forming apparatus 三菱化学株式会社 2022-11-11 CN claimed
US-6835755-B1 Naphthoquinone derivatives and their use in the treatment and control of tuberculosis UNIVERSITY OF PRETORIA (ZA) 2004-12-28 US claimed
EP-1194137-A2 NAPHTHOQUINONE DERIVATIVES AND THEIR USE IN THE TREATMENT AND CONTROL OF TUBERCULOSIS University of Pretoria (ZA) 2002-04-10 EP claimed
WO-2001000554-A2 NAPHTHOQUINONE DERIVATIVES AND THEIR USE IN THE TREATMENT AND CONTROL OF TUBERCULOSIS UNIVERSITY OF PRETORIA (ZA) 2001-01-04 WO claimed
EP-0653441-B1 Polymer scale preventive agent SHINETSU CHEMICAL CO (JP) 1998-02-04 EP claimed
EP-0653441-A1 Polymer scale preventive agent SHIN-ETSU CHEMICAL CO., LTD. (JP) 1995-05-17 EP claimed
CN-116507975-A Electrophotographic photoreceptor, cartridge using the same, and image forming apparatus 三菱化学株式会社 2023-07-28 CN disclosed
CN-116406455-A Electrophotographic photoreceptor, electrophotographic photoreceptor cartridge, and image forming apparatus 三菱化学株式会社 2023-07-07 CN disclosed
CN-115335777-A Electrophotographic photoreceptor, electrophotographic photoreceptor cartridge, and image forming apparatus 三菱化学株式会社 2022-11-11 CN disclosed
US-20200283417-A1 AZIRIDINYL AND AMINO DIMERIC NAPHTHOQUINONE COMPOUNDS AND USE FOR ACUTE MYELOID LEUKEMIA UNIVERSITY OF MARYLAND, BALTIMORE 2020-09-10 US disclosed
CN-105911822-B Electrophotographic photoreceptor, process cartridge, and image forming apparatus 富士施乐株式会社 2019-12-06 CN disclosed
WO-2018067842-A1 AZIRIDINYL AND AMINO DIMERIC NAPHTHOQUINONE COMPOUNDS AND USE FOR ACUTE MYELOID LEUKEMIA UNIVERSITY OF MARYLAND, BALTIMORE (US) 2018-04-12 WO disclosed
EP-1194137-B1 NAPHTHOQUINONE DERIVATIVES AND THEIR USE IN THE TREATMENT AND CONTROL OF TUBERCULOSIS UNIV PRETORIA (ZA) 2004-12-29 EP disclosed
US-6835755-B1 Naphthoquinone derivatives and their use in the treatment and control of tuberculosis UNIVERSITY OF PRETORIA (ZA) 2004-12-28 US disclosed
EP-1194137-A2 NAPHTHOQUINONE DERIVATIVES AND THEIR USE IN THE TREATMENT AND CONTROL OF TUBERCULOSIS University of Pretoria (ZA) 2002-04-10 EP disclosed
WO-2001000554-A2 NAPHTHOQUINONE DERIVATIVES AND THEIR USE IN THE TREATMENT AND CONTROL OF TUBERCULOSIS UNIVERSITY OF PRETORIA (ZA) 2001-01-04 WO disclosed
EP-0653441-B1 Polymer scale preventive agent SHINETSU CHEMICAL CO (JP) 1998-02-04 EP disclosed
US-5492982-A MIXTURE OF NAPHTHOQUINONE DIMER, WATER SOLUBLE POLYMER AND AN INORGANIC COLLOID SHIN-ETSU CHEMICAL CO., LTD. (JP) 1996-02-20 US disclosed
EP-0653441-A1 Polymer scale preventive agent SHIN-ETSU CHEMICAL CO., LTD. (JP) 1995-05-17 EP disclosed
US-5292873-A Nucleic acids labeled with naphthoquinone probe THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1994-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200283417-A1 AZIRIDINYL AND AMINO DIMERIC NAPHTHOQUINONE COMPOUNDS AND USE FOR ACUTE MYELOID LEUKEMIA MCL1, NPM1, ABL1 BACE1 4773/4885CDC25B 502/4885IDO1 494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.